BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23249693)

  • 21. Hypoxia stimulates CXCR4 signalling in ileal carcinoids.
    Arvidsson Y; Bergström A; Arvidsson L; Kristiansson E; Ahlman H; Nilsson O
    Endocr Relat Cancer; 2010 Jun; 17(2):303-16. PubMed ID: 20071457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis.
    Neklyudova O; Arlt MJ; Brennecke P; Thelen M; Gvozdenovic A; Kuzmanov A; Robl B; Botter SM; Born W; Fuchs B
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1739-50. PubMed ID: 27300512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP; Wu XH; Xing HY; DU XY
    Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
    Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
    Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL12/SDF-1α induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells.
    Cheng Y; Qu J; Che X; Xu L; Song N; Ma Y; Gong J; Qu X; Liu Y
    Oncol Lett; 2017 Aug; 14(2):2103-2110. PubMed ID: 28781651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines.
    Di Cesare S; Marshall JC; Fernandes BF; Logan P; Antecka E; Filho VB; Burnier MN
    Cancer Cell Int; 2007 Nov; 7():17. PubMed ID: 18001467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.
    Mao TL; Fan KF; Liu CL
    Gene Ther; 2017 Oct; 24(10):621-629. PubMed ID: 28753202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
    Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
    Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
    Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
    Sorrentino C; Miele L; Porta A; Pinto A; Morello S
    Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.
    Tamas K; Domanska UM; van Dijk TH; Timmer-Bosscha H; Havenga K; Karrenbeld A; Sluiter WJ; Beukema JC; van Vugt MA; de Vries EG; Hospers GA; Walenkamp AM
    Curr Pharm Des; 2015; 21(17):2276-83. PubMed ID: 25557636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
    Phillips RJ; Burdick MD; Lutz M; Belperio JA; Keane MP; Strieter RM
    Am J Respir Crit Care Med; 2003 Jun; 167(12):1676-86. PubMed ID: 12626353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanoma metastases express functional CXCR4.
    Scala S; Giuliano P; Ascierto PA; Ieranò C; Franco R; Napolitano M; Ottaiano A; Lombardi ML; Luongo M; Simeone E; Castiglia D; Mauro F; De Michele I; Calemma R; Botti G; Caracò C; Nicoletti G; Satriano RA; Castello G
    Clin Cancer Res; 2006 Apr; 12(8):2427-33. PubMed ID: 16638848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.